ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 54 | -48.1% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 104 | +76.3% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 59 | -39.8% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 98 | +50.8% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -99.2% | 65 | -98.6% | 0.00% | -100.0% |
| Q4 2020 | $253,000 | +29.7% | 4,730 | 0.0% | 0.04% | +15.2% |
| Q3 2020 | $195,000 | -14.8% | 4,730 | 0.0% | 0.03% | -21.4% |
| Q2 2020 | $229,000 | +14.5% | 4,730 | 0.0% | 0.04% | -2.3% |
| Q1 2020 | $200,000 | +65.3% | 4,730 | +67.1% | 0.04% | +115.0% |
| Q4 2019 | $121,000 | +18.6% | 2,830 | 0.0% | 0.02% | +11.1% |
| Q3 2019 | $102,000 | +34.2% | 2,830 | 0.0% | 0.02% | +38.5% |
| Q2 2019 | $76,000 | 0.0% | 2,830 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $76,000 | +65.2% | 2,830 | 0.0% | 0.01% | +30.0% |
| Q4 2018 | $46,000 | -22.0% | 2,830 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $59,000 | +37.2% | 2,830 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $43,000 | -32.8% | 2,830 | 0.0% | 0.01% | -33.3% |
| Q1 2018 | $64,000 | -24.7% | 2,830 | 0.0% | 0.01% | -20.0% |
| Q4 2017 | $85,000 | -20.6% | 2,830 | 0.0% | 0.02% | -25.0% |
| Q3 2017 | $107,000 | +35.4% | 2,830 | 0.0% | 0.02% | +25.0% |
| Q2 2017 | $79,000 | – | 2,830 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |